Search - tctmd.com

Displaying 101 - 120 of 260

Sort: Relevancy | Date

Presentation TCT 2020

TCT 391: 10-Year Outcomes After Drug-Eluting Stent Placement in Women Versus Men

Presenter: Nicole Pristera

October 14, 2020

Presentation TCT 2020

TCT 390: Safety and Efficacy of Sirolimus-Eluting Stent System in All-Comers Real-World Population With Coronary Artery Stenosis: The MILES-Global Study

Presenter: Martin Hudec

October 14, 2020

Presentation TCT 2020

TCT 381: Predictors of Ischemic and Bleeding Outcomes in High Bleeding Risk Patients Implanted With the SYNERGY Stent – A Post-Hoc Analysis From the EVOLVE Short DAPT Study

Presenter: Robert Yeh

October 14, 2020

Presentation TCT 2020

TCT 380: 2-Years Results of the Novel Sirolimus Eluting Stent in an All-comer High-risk Population

Presenter: Luca Testa

October 14, 2020

Presentation TCT 2020

TCT 287: Treatment of Patients With Recurrent In-Stent Restenosis Who Failed Intravascular Brachytherapy

Presenter: Charan Yerasi

October 14, 2020

Presentation TCT 2020

TCT 290: Evaluating the Long-term Clinical Outcomes of Different Treatment Modalities for Intra-stent Chronic Total Occlusion

Presenter: Sandeep Basavarajaiah

October 14, 2020

Presentation TCT 2020

TCT 286: Long-Term Outcomes Following Drug-Eluting Balloon Versus Thin-Strut Drug-Eluting Stents for Treatment of In-Stent Restenosis: Multicenter Propensity Score-Matched Analysis (DEB-Dragon Registry)

Presenter: Wojciech Wanha

October 14, 2020

Presentation TCT 2020

TCT 249: Real-world Dual Antiplatelet Therapy Following Polymer-free, Sirolimus-Eluting Stent Implantations to Treat Coronary Artery Disease

Presenter: Markus Krackhardt

October 14, 2020

Presentation TCT 2020

TCT 262: Percutaneous Coronary Intervention of Long Coronary Lesions With the Bioabsorbable Polymer-Coated, Everolimus-Eluting SYNERGY 48 mm Stent: Primary Outcomes of the EVOLVE 48 Study

Presenter: Dimitri Karmpaliotis

October 14, 2020

Presentation TCT 2020

TCT 260: A Prospective Randomized Multicenter Study to Assess the Safety and Effectiveness of the Orsiro Sirolimus Eluting Stent in the Treatment of Subjects With up to Two De Novo Coronary Artery Lesions – BIOFLOW IV: 5 Year Clinical Results

Presenter: Bernhard Witzenbichler

October 14, 2020

Presentation TCT 2020

TCT 267: BIOVITESSE – Multicenter Prospective First-In-Man Study of a New Polymer Free Drug-coated Stent With Ultrathin Struts: Clinical Study Outcome

Presenter: Lorenz Raber

October 14, 2020

Presentation TCT 2020

TCT 266: Cobalt Chromium Biolimus Drug-Eluting Stents Compared With Stainless Steel Biolimus Drug-Eluting Stents: Final Results of BMX Alpha

Presenter: Ian Brian Alexander Menown

October 14, 2020

Presentation TCT 2020

TCT 257: Drug-Coated Balloon Versus Drug-Eluting Stent for the Treatment of Small Vessel Disease: 3-Year Clinical Outcomes of the RESTORE SVD China Randomized Trial

Presenter: Jian Tian

October 14, 2020

Presentation TCT 2020

TCT 276: A 'Real-World' Multi-center Registry Evaluating Safety and Clinical Performance of Biodegradable Polymer-coated Ultra-thin Everolimus-eluting Stents: 3-year Results from the PERFORM-EVER Registry

Presenter: Sridhar Kasturi, MD

October 14, 2020

Presentation TCT 2020

TCT 193: Radiation Exposure, Safety and Clinical Outcomes Following Interventional Coronary Diagnostic Procedures When Performed Without Planned Coronary Stenting

Presenter: Amreen Kaur

October 14, 2020

Presentation TCT 2020

TCT 163: Risk of Coronary Artery Bypass Graft in the 10 Years After Drug Eluting Stents

Presenter: Parth Parikh

October 14, 2020

Presentation TCT 2020

TCT 067: Antithrombotic Treatment Strategies in Patients Older than 75 Years With Atrial Fibrillation After Percutaneous Coronary Intervention With Drug-Eluting Stents. The PACO-PCI Registry

Presenter: Jose de la Torre Hernandez

October 14, 2020

News Daily News

Diabetes Influences Relative Effects of Ticagrelor, Prasugrel in ACS: ISAR-REACT 5

Todd Neale

October 09, 2020

News Opinion Editor's Corner TCT 2020

TCT 2020: Short DAPT, Longer TAVR Outcomes, Intravascular Imaging, and More

Shelley Wood

October 09, 2020

News Daily News

Features of Complex CAD Carry Progressive Risk in PCI, Registry Confirms

Caitlin E. Cox

October 08, 2020

Advertisement

TCT 391: 10-Year Outcomes After Drug-Eluting Stent Placement in Women Versus Men

TCT 390: Safety and Efficacy of Sirolimus-Eluting Stent System in All-Comers Real-World Population With Coronary Artery Stenosis: The MILES-Global Study

TCT 381: Predictors of Ischemic and Bleeding Outcomes in High Bleeding Risk Patients Implanted With the SYNERGY Stent – A Post-Hoc Analysis From the EVOLVE Short DAPT Study

TCT 380: 2-Years Results of the Novel Sirolimus Eluting Stent in an All-comer High-risk Population

TCT 287: Treatment of Patients With Recurrent In-Stent Restenosis Who Failed Intravascular Brachytherapy

TCT 290: Evaluating the Long-term Clinical Outcomes of Different Treatment Modalities for Intra-stent Chronic Total Occlusion

TCT 286: Long-Term Outcomes Following Drug-Eluting Balloon Versus Thin-Strut Drug-Eluting Stents for Treatment of In-Stent Restenosis: Multicenter Propensity Score-Matched Analysis (DEB-Dragon Registry)

TCT 249: Real-world Dual Antiplatelet Therapy Following Polymer-free, Sirolimus-Eluting Stent Implantations to Treat Coronary Artery Disease

TCT 262: Percutaneous Coronary Intervention of Long Coronary Lesions With the Bioabsorbable Polymer-Coated, Everolimus-Eluting SYNERGY 48 mm Stent: Primary Outcomes of the EVOLVE 48 Study

TCT 260: A Prospective Randomized Multicenter Study to Assess the Safety and Effectiveness of the Orsiro Sirolimus Eluting Stent in the Treatment of Subjects With up to Two De Novo Coronary Artery Lesions – BIOFLOW IV: 5 Year Clinical Results

TCT 267: BIOVITESSE – Multicenter Prospective First-In-Man Study of a New Polymer Free Drug-coated Stent With Ultrathin Struts: Clinical Study Outcome

TCT 266: Cobalt Chromium Biolimus Drug-Eluting Stents Compared With Stainless Steel Biolimus Drug-Eluting Stents: Final Results of BMX Alpha

TCT 257: Drug-Coated Balloon Versus Drug-Eluting Stent for the Treatment of Small Vessel Disease: 3-Year Clinical Outcomes of the RESTORE SVD China Randomized Trial

TCT 276: A 'Real-World' Multi-center Registry Evaluating Safety and Clinical Performance of Biodegradable Polymer-coated Ultra-thin Everolimus-eluting Stents: 3-year Results from the PERFORM-EVER Registry

TCT 193: Radiation Exposure, Safety and Clinical Outcomes Following Interventional Coronary Diagnostic Procedures When Performed Without Planned Coronary Stenting

TCT 163: Risk of Coronary Artery Bypass Graft in the 10 Years After Drug Eluting Stents

TCT 067: Antithrombotic Treatment Strategies in Patients Older than 75 Years With Atrial Fibrillation After Percutaneous Coronary Intervention With Drug-Eluting Stents. The PACO-PCI Registry

Diabetes Influences Relative Effects of Ticagrelor, Prasugrel in ACS: ISAR-REACT 5

TCT 2020: Short DAPT, Longer TAVR Outcomes, Intravascular Imaging, and More

Features of Complex CAD Carry Progressive Risk in PCI, Registry Confirms

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content